Calpains I and II are calcium-dependent proteases that have been implicated in several aspects of brain function, including neurofilament turnover, Wallerian degeneration, and excitatory synaptic transmission. In this study, specific affinity-purified antibodies against each of the enzymes were used to determine their cellular distribution in rat brain. Differences between the two were found throughout the brain, with calpain I being located primarily in neurons, whereas calpain II was more prominent in glial cells. In myelinated axons, calpain II was present at low levels but calpain I was not detectable. In all brain areas, both enzymes were concentrated in cell bodies, with lesser amounts in neuronal and glial processes. Calpain I was only detectable proximally in dendrites and was not found in spiny branchlets of either pyramidal or Purkinje cells. These results suggest that calpain II is the likely form of the enzyme involved in calcium-activated proteolytic phenomena in axons. They do not support the existence of a role for calpain at excitatory axospinous synapses.
Distribution of Calpains I and II in Rat Brain
Calpains I and II are calcium-dependent proteases that have been implicated in several aspects of brain function, including neurofilament turnover, Wallerian degeneration, and excitatory synaptic transmission. In this study, specific affinity-purified antibodies against each of the enzymes were used to determine their cellular distribution in rat brain. Differences between the two were found throughout the brain, with calpain I being located primarily in neurons, whereas calpain II was more prominent in glial cells. In myelinated axons, calpain II was present at low levels but calpain I was not detectable. In all brain areas, both enzymes were concentrated in cell bodies, with lesser amounts in neuronal and glial processes. Calpain I was only detectable proximally in dendrites and was not found in spiny branchlets of either pyramidal or Purkinje cells. These results suggest that calpain II is the likely form of the enzyme involved in calcium-activated proteolytic phenomena in axons. They do not support the existence of a role for calpain at excitatory axospinous synapses.
Calpain (EC 3.4.22.17 ; @+-dependent cysteine proteinase), first discovered in rat brain (Guroff, 1964) , is now known to be widely distributed in various animal species (Murachi et al., 1981a) . Two forms of calpain, which differ in their CaZ+ requirement, have been identified: low-(or PM concentration) Ca2+-requiring calpain I and high-(or mM concentration) CaZ+-requiring calpain II (Mellgren, 1980; Murachi et al., 198 lb) . Both calpains I and II are known to be composed of one heavy (approximately 80 kDa) and one light (approximately 30 kDa) subunit. The heavy subunits, each of which contains the active site cysteine residue, differ chemically and immunologically between calpains I and II, whereas the light subunits, whose function is not fully understood, are most probably identical Sasaki et al., 1984; Wheelock, 1982) .
While calpains I and II are very widely distributed in various tissues and cells, both the absolute and relative abundance of the two calpains are markedly different from one tissue to another (for a recent review, see Murachi, 1984) . In nervous tissue, calpain has been detected in axoplasm from the giant axon of Myxicolu (Gilbert and Newby, 1975) , in squid (Pant et al., 1979) , and in rat peripheral nerve (Kamakura et al., 1983; Schlaepfer and Freeman, 1980) . These authors reported selective degradation of axonal neurofilaments and the enzyme's requirement of CaZ+ at the millimolar level for maximal activity, which suggests that the enzyme involved was calpain II. Other investigators reported the existence of a low-Ca*+-requiring form, calpain I, in the rat spinal cord (Ishizaki et al., 1983; Tashiro and Ishizaki, 1982) . Siman et al. (1983) have reported the recovery of both calpains I and II from synaptosomal plasma membrane, and Lynch and Baudry (1984) have proposed a hypothesis that calpain is involved in the regulation of hippocampal glutamate receptors, which these authors relate to the phenomenon of long-term memory.
A large number of cellular proteins have been reported to be susceptible to calpains (for a review, see Murachi, 1984) but it is still unclear whether all of these proteins are true natural substrates of calpain and, hence, what the true physiological role of calpain inside a cell might be. In view of the wide variety of substrates for calpains in vitro, the localization of the two forms of the enzyme is critical in evaluating their proposed roles in the nervous system. As an approach to this problem, we have studied the distributions of calpains I and II in rat brain using specific antibodies that can discriminate between these 2 enzymes .
Materials and Methods
Preparation of antibodies Two antibodies directed, respectively, against the calpain I 80 kDa subunit and the calpain II 80 kDa subunit were obtained from rabbits immunized with porcine erythrocyte calpain I 80 kDa subunit and porcine kidney calpain II 80 kDa subunit. Each IgG fraction was further purified by 2-step affinity chromatography, using the appropriate 80 kDa subunit protein as the immobilized ligand .
Their mutually discriminative specificity has previously been established using gel blots of purified calpains and porcine kidney protein . In all experiments both antibodies were used at 0.05 mg/ml of protein.
Immunochemical procedures Whole brain tissues were homogenized with a Dounce homogenizer in 3 volumes of ice-cold 20 mM Tris-buffered saline containing 1 mM EGTA, 5 mM mercaptoethanol, and 0.25 M sucrose. After centrifugation at 105,000 x g for 1 hr, the supernatant was collected. Proteins of the supematant were separated by SDS-PAGE according to the method of Laemmli (1970) , using gels containing 7.5% polyacrylamide. Protein blotting onto nitrocellulose membrane (Towbin et al., 1979) and the subsequent immunochemical staining (Matus et al., 1980) were performed as described.
Immunohistochemistry Sprague-Dawley rats, aged 0, 10, 15, 20, and 45 d, and adult animals (older than 70 d) were fixed by transcardiac perfusion under Nembutal anesthesia, using 4% paraformaldehyde and 0.75% glutaraldehyde in 50 mM PBS. Tissue was sectioned at 40 pm using a Vibratome (Oxford). During this procedure, tissues were kept at 4°C in Tris-buffered saline. The sections were transferred into 24-well plastic plates, and stained with the antibodies according to the peroxidase-antiperoxidase technique at room temperature, using 4-chloro-1 -naphthol as a chromogen (Bemhardt and Matus, 1984) . All solutions used were supplemented with 0.05% Tween-20 to reduce nonspecific staining. The control runs, omitting the first antibody (anti-calpain antibody), gave no positive stainings. Figure 1 . Western blots of the supematant fraction of total brain homogenate. The proteins were separated by SDS-gel electrophoresis, blotted onto nitrocellulose, and stained for protein (P) or with anti-calpain I (I) or anti-calpain II (2).
Results

Specificity of the antibodies
To test whether the antibodies were specific for calpain I and II, respectively, we checked their reactions with the proteins in the supernatant (cytosol) fraction of total rat brain homogenate.
As is shown in Figure 1 , each antibody reacted with 1 major protein, which was of a molecular size appropriate to each calpain. The specificity of the 2 antibodies was also indicated by the characteristic staining patterns they gave in brain sections. These were distinct from staining patterns obtained using the same immunoperoxidase technique with rabbit antisera against other brain proteins (e.g., actin: Matus et al., 1982 ; microtubule-associated protein 2: Bernhardt and Matus, 1984; synaptic membrane proteins: Matus et al., 1984) . In addition, characteristic differences were found between the staining patterns with anticalpain I and anti-calapin II. These are described below for 3 major brain regions. For each antibody, the same characteristic pattern was found throughout the brain. 
Distribution in cerebellum
As is shown in Figure 2A , anti-calpain I stained Purkinje cell bodies and their proximal dendrites. Staining intensity was strongest in the Purkinje cell layer, and weaker staining was also observed in the granule cell layer and in interneurons in the molecular layer (ml, Fig. 2A ). Anti-calpain II gave a different pattern, in which the radial processes of Bergmann glia were the most prominent feature (Fig. 2B) . At higher magnification, the difference between the staining patterns of anti-calpain I and II was clear (Fig. 3, A, B) . Purkinje cell bodies were intensely stained by anti-calpain I and a weaker reaction was also present in the proximal dendrites (Fig. 3A) . The soma of intemeurons were also stained but no staining of processes was detectable. These were the only cellular elements of the cerebellar cortex that showed distinct and reproducible calpain I reactivity. Anticalpain II produced weaker staining of Purkinje cell bodies; in most cells it was extremely faint (for example, the cells labeled P, and P, in Fig. 3B ). There were, however, occasional cells that had a stronger reaction (e.g., P, in Fig. 3B ). Much more consistent was the staining of Bergmann glial cell bodies ("g" in Fig. 3B ) and their processes. There was no consistent staining of intemeurons by anti-&pain II, either in the granule cell or molecular layers.
Both antibodies produced some staining in the proximal dendrites of Purkinje cells, but neither stained the fine branchlets bearing the axospinous synapses of these cells. Another marked difference was seen in the central white matter (Fig. 4) . Anticalpain II clearly reacted with myelinated axons, though the staining intensity was weak. By contrast, staining with anticalpain I produced no positive reaction. 
Distribution in cerebral cortex
The staining pattern in the neocortex was similar to that in the cerebellum. Anti-calpain I mainly stained neuronal cell bodies and the proximal part of their processes (Fig. 5, A, C) . On the other hand, anti-calpain II reacted rather strongly with glial cells (Fig. 5, B, D) . Endothelial cells of blood vessels and the glial cells that had contact with blood vessels were stained with anticalpain II. Glial cells stained with anti-calpain II were conspicuous in the area near the pial surface.
Distribution in hippocampus
A striking difference between the anti-&pain I and II staining was seen in hippocampus. As is shown in Figure 6 , anti-calpain I stained mainly pyramidal cells, while anti-calpain II predominantly stained glial cells. The staining intensity of anti-calpain I was strongest in the cell body and decreased rapidly in the proximal dendrites. Here again, as in the cerebellum, no positive reaction was seen in the fine spiny branchlets of pyramidal cells. The same staining patterns were seen in dentate gyrus (Fig. 7) . 
Distributional change during development
We followed the staining pattern of both antibodies during the development of rat brain. Figure 8 shows sections of hippocampus where the distributional changes were most clearly observed. Anti-calpain I mainly stained neuronal cell bodies and their proximal dendrites at every age examined (O-45 days). This was the same staining pattern as that in adult animals (older than 70 d; see Fig. 6 ). Anti-calpain II, however, produced a different pattern in young than in adult animals. The change of staining pattern occurred around 20 d after birth. In 0-, lo-, and 15-dold rats, anti-calpain II reacted with neuronal cells and their dendrites, a pattern very similar to that obtained with anticalpain I. In 20-d-old rats, anti-calpain II also began to stain glial cells, while the staining intensity in neuronal cells decreased. In 45-d-old rats, the staining pattern of anti-calpain II was almost the same as that in adult animals. We also examined the staining pattern of both antibodies in a 2-year-old rat and found no difference from that in young adult rats, except that the immunoreaction was very weak (data not shown).
Discussion
We report in this paper the immunohistochemical localization of calpains I and II, 2 distinctive forms of Ca2+-dependent cysteine proteinases, in rat brain. The use of affinity-purified antibodies directed, respectively, against calpain I (FM-Ca2+-requiring form) and calpain II (mM-Cal+-requiring form) enabled us to demonstrate common features as well as differences in their distribution in brain tissue.
One of the features common to both calpains I and II was that they were concentrated mainly in cell bodies. Proximal dendrites were stained, though to a lesser extent than cell bodies, but the distal portions were unstained (Figs. 3, 5, and 6 ). These results indicate that the cell body contains the major concentration of calpain protein. This suggests that. the cell body is a major site of calpain action, but this is subject to the caveat that our present data do not prove that immunostained protein corresponds to active enzyme. Our results also support the proposition made by previous investigators (Ishizaki et al., 1983; Kamakura et al., 1983; Schlaepfer and Freeman, 1980 ) that calpain may be involved in the degradation of axonal proteins. Figure 4 shows that calpain II, not calpain I, is localized in the myelinated axons in the central white matter, making it possible that calpain II is the degradative enzyme responsible for Wallerian degeneration.
The uneven distribution of calpains I and II in different tissues has long been recognized (see, for review, Murachi, 1984 ). The present study shows that distinct differences between calpains I and II also exist at the cellular level. Throughout the brain, calpain I is mainly localized in neuronal cells, whereas calpain II is more prominent in glial cells. This may imply a difference in physiological function between calpains I and II. Although little is known about the in vivo actions of calpains, it has been proposed that they may act to terminate cytoskeletal extension under the regulation of calcium fluxes (Lasek and Hoffman, 1976) . The presence of micromolar-activated calpain I in proximal segments of neuronal processes and of millimolar-activated calpain II in myelinated axons suggests that these 2 enzymes may program varying sensitivities of cytoskeletal structures to local calcium fluxes in different neuronal microdomains.
The differences in the cellular patterns of expression of calpains I and II during brain development suggest functional differences between the 2 enzymes. It is interesting to note that mature erythrocytes, like post-mitotic neurons, contain calpain I but not calpain II Murachi et al., 198 1 a) , while almost all other tissues and cells so far examined contain both. During the early phase of brain development, we stained neurons with both anti-calpain I and anti-calpain II, and the disappearance of calpain II from these cells began at about postnatal day 20, when the major phase of axon and dendrite growth is ending. This corresponds to the end of the period when neuronal microtubules undergo a transition in their chemical composition, which includes marked declines in neuronal levels of several microtubule-associated proteins (Bemhardt et al., 1985; Calvert and Anderton, 1985; Riederer and Matus, 1985) . Lynch and Baudry (1984) have proposed a hypothesis that the calpain I associated with post-synaptic membranes of synapses on hippocampal neurons plays a role in the mechanism of memory. They recovered the enzyme from crude subcellular fractions containing synaptosomal plasma membrane and dem- Vol. 6, No. 11, Nov. 1986 onstrated that it up-regulated the number of glutamate receptors by cleaving fodrin in a Ca2+-dependent manner. If this were the case, then positive staining with anti-calpain I would be expected at synaptic sites on dendrites in hippocampus, where the glutamate receptors are known to be abundant. Contrary to this expectation, we found no such membrane-associated localization of calpain I, either in hippocampus (Fig. 6) neocortex (Fig.  5) or cerebellum (Fig. 3) . It is unlikely that this was the result of a failure in the immunohistochemical methods we employed because, using exactly the same techniques, we were able to stain dendritic spines with anti-actin (Matus et al., 1982) and locate synaptic plasma membrane proteins at synapses .
There is thus a discrepancy between the recovery of calpain from membranes by Siman et al. (1983) and the absence of synaptic staining by anti-&pain reported here. One possible explanation lies in the nature of the membranes that Siman et al. used. They were derived, not from synaptosomes, but from the crude P, pellet that contains membranes of mitochondrial, myelin, and undefined origin. Such preparations are well suited to investigating neurotransmitter receptors, where the object under study is defined by its pharmacological properties (Snyder and Goodman, 1980) , but, because of their heterogeneity, it is difficult to use them to unequivocally identify a protein with a specific subcellular organelle. Siman et al. (1983) extracted calpain from the P, membranes by incubating them overnight in low-ionic-strength buffer, indicating that the recovered calpain was weakly attached to the membrane periphery. It is known that synaptic membranes, and particularly the synaptic junctional structures they contain, bind foreign proteins in brain homogenates nonspecifically. This has been demonstrated for myelin basic protein (Cohen et al., 1977) and neurofilament proteins (Matus et al., 1980) . The same possibility exists for soluble proteins such as the calpains that in tissue homogenates may adsorb to synaptic membranes to which they are not normally exposed in intact cells. Despite these problems, it is still possible that membrane-associated calpain exists in a form with different antigenicity from cytosolic calpain I, or that the antigenie epitope of membrane-associated calpain is hidden by its association with other proteins or lipids. Nevertheless, the present results do not provide any direct support for the existence of a role for calpain I at the synaptic site.
After this manuscript was submitted for publication, Siman et al. (1985) published a report of the immunohistochemical localization of calpain I in the brain. Their results are similar to ours in that calpain I immunoreactivity occurs in neuronal cell bodies and is mainly concentrated in the soma and proximal dendrites. They also find calpain I antigen in glia and axon tracts, whereas our results suggest that calpain II is the predominant form at these sites.
